{"id":15333,"name":"Springhood Ventures","slug":"springhood-ventures","website":"https://www.springhood.com/","hqGeo":null,"stageFocus":["Seed"],"sectorTags":["Other","Healthcare","Developer Tools"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"The first venture capital investor focused broadly on children's health, backing young companies with a clear commercial pathway to improve child health outcomes.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"NextGen","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"clinical decision support addressing the 'discharge dilemma'","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Rare Disease Diagnostics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Reducing rare disease diagnostic journey from 7 years to 3 months","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Small Molecule Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Developing new small molecule therapeutics for difficult-to-treat cancers - starting with DIPG","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Intravenous Recombinant Human Decorin","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Developing intravenous recombinant human decorin to treat dystrophic epidermis bullosa","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Bedside Empowerment Technology","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Bedside empowerment technology for parents with babies in the neonatal intensive care unit (NICU)","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Targeted Therapy for Duchenne Muscular Dystrophy","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Developing a targeted therapy for bone and muscle wastage in Duchenne muscular dystrophy","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Neonatal Opioid Withdrawal Syndrome Treatment","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Treating Neonatal Opioid Withdrawal Syndrome and other infant respiratory disorders","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Lightweight MRI-Receive Coils","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Lightweight MRI-receive coils designed for pediatric patients","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Clinical Decision Support Tool","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Clinical decision support tool for ASD and other neurological conditions","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Preterm Infant Feeding Standard","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Changing the standard of care for preterm infant feeding","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Infant Spinal Tap Positioning Solution","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Revolutionary infant spinal tap positioning solution","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Medulloblastoma Treatment","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Improving treatment and quality of survival for children battling medulloblastoma","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Affordable Medical Innovations","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Transforming healthcare in emerging markets with affordable, life-saving medical innovations","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Neuroprotectant for HIE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Neuroprotectant for use in neonatal hypoxic-ischemic encephalopathy (HIE)","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Biologic Therapy for NEC","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biologic therapy to prevent and treat necrotizing enterocolitis in newborns","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Retinopathy of Prematurity Therapies","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Developing safe, effective therapies for retinopathy of prematurity and drug-induced hearing loss in children","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Broad Spectrum Blood Test for Autism","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Developing the first broad spectrum blood test for Autism Spectrum Disorders","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"HIV Prevention","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Helping reduce the number of children born with HIV","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Umbilical Catheter Protection","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Revolutionizing umbilical catheter protection and securement","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Genetic Screening","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Genetic screening with ongoing genomic-guided care","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Noninvasive Monitoring","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Noninvasively monitoring central venous oxygenation","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Targeted Bacteria-Mediated Therapy","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Targeted bacteria-mediated therapy for patients with neurofibromatosis Type 2","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Clinical Knowledge for Everyone","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Saving lives by providing clinical knowledge to everyone, everywhere, starting with children","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Reducing Infant Mortality","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Reducing infant mortality and morbidity in low-resource settings","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NeoPredics","companyUrl":null,"stage":"Early funding / early-stage","sector":"Healthcare / predictive analytics","investmentYear":null,"description":"Predictive analytics for neonatal, maternal, and perinatal health","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":1,"partners":[{"id":49624,"name":"John Parker","title":"Managing Partner","seniority":null,"focusTags":["child health innovation"],"linkedinUrl":"https://www.linkedin.com/in/john-o-parker","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":"John Parker founded Springhood to address the funding gap in child health innovation. He has brought 25 years in the alternative investment industry together with over a decade of philanthropic experience to create a new model using investment dollars to make a difference in the lives of kids. This model has emerged from his work as the Founder and Managing Director of CH Innovations, LLC, a child health venture fund backed by the Charles H. Hood Foundation, where he also serves as a Trustee.","recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Other","Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":14773,"name":"Joule Ventures","slug":"joule-ventures-14773","logoUrl":null,"website":"https://jouleventures.com/","stageFocus":["Seed"],"sectorTags":["Other","Enterprise","Developer Tools","Security","AI / ML","Fintech"],"hqGeo":"Tel Aviv, Israel"},{"id":13015,"name":"Nile Ventures","slug":"nile-ventures-13015","logoUrl":null,"website":"https://www.choosenile.com/","stageFocus":["Pre-Seed"],"sectorTags":["Healthcare","SaaS"],"hqGeo":"Lagos, Nigeria"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Other","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":10202,"name":"Celestial Health Innovators","slug":"celestial-health-innovators","logoUrl":null,"website":"https://celestialhealthwellness.co/","stageFocus":["seed+","Series A"],"sectorTags":["Healthcare","Other"],"hqGeo":"New York, NY"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"},{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"},{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-13T21:27:10.660Z"}